Year |
Citation |
Score |
2024 |
Lee JC, Shirey RJ, Turner LD, Park H, Lairson LL, Janda KD. Discovery of PLD4 modulators by high-throughput screening and kinetic analysis. Results in Chemistry. 7. PMID 38560090 DOI: 10.1016/j.rechem.2024.101349 |
0.396 |
|
2022 |
Lee JC, Eubanks LM, Zhou B, Janda KD. Development of an Effective Monoclonal Antibody against Heroin and Its Metabolites Reveals Therapies Have Mistargeted 6-Monoacetylmorphine and Morphine over Heroin. Acs Central Science. 8: 1464-1470. PMID 36313156 DOI: 10.1021/acscentsci.2c00977 |
0.46 |
|
2022 |
Lee JC, Park H, Eubanks LM, Ellis B, Zhou B, Janda KD. A Vaccine against Benzimidazole-Derived New Psychoactive Substances That Are More Potent Than Fentanyl. Journal of Medicinal Chemistry. PMID 34994550 DOI: 10.1021/acs.jmedchem.1c01967 |
0.401 |
|
2021 |
Lee JC, Janda KD. Development of effective therapeutics for polysubstance use disorders. Current Opinion in Chemical Biology. 66: 102105. PMID 34936944 DOI: 10.1016/j.cbpa.2021.102105 |
0.425 |
|
2021 |
Lin M, Lee JC, Blake S, Ellis B, Eubanks LM, Janda KD. Broadly Neutralizing Synthetic Cannabinoid Vaccines. Jacs Au. 1: 31-40. PMID 34467269 DOI: 10.1021/jacsau.0c00057 |
0.418 |
|
2021 |
Lee JC, Janda KD. Immunopharmacotherapeutic advancements in addressing methamphetamine abuse. Rsc Chemical Biology. 2: 77-93. PMID 34458776 DOI: 10.1039/d0cb00165a |
0.449 |
|
2021 |
Park H, Lee JC, Eubanks LM, Ellis B, Zhou B, Janda KD. Improvements on a chemically contiguous hapten for a vaccine to address fentanyl-contaminated heroin. Bioorganic & Medicinal Chemistry. 41: 116225. PMID 34034147 DOI: 10.1016/j.bmc.2021.116225 |
0.445 |
|
2020 |
Lee JC, Kim HY, Lee S, Shin J, Kim HV, Kim K, Baek S, Lee D, Jeon H, Kim D, Yang SH, Han G, Park K, Choi J, Park J, et al. Discovery of chemicals to clear or indicate amyloid aggregates by targeting memory-impairing anti-parallel Aβ dimers. Angewandte Chemie (International Ed. in English). PMID 32233096 DOI: 10.1002/Anie.202002574 |
0.526 |
|
2019 |
Lee JC, Kim SJ, Hong S, Kim Y. Diagnosis of Alzheimer's disease utilizing amyloid and tau as fluid biomarkers. Experimental & Molecular Medicine. 51: 53. PMID 31073121 DOI: 10.1038/S12276-019-0250-2 |
0.559 |
|
2019 |
Kim Y, Yoo YK, Kim HY, Roh JH, Kim J, Baek S, Lee JC, Kim HJ, Chae MS, Jeong D, Park D, Lee S, Jang H, Kim K, Lee JH, et al. Comparative analyses of plasma amyloid-β levels in heterogeneous and monomerized states by interdigitated microelectrode sensor system. Science Advances. 5: eaav1388. PMID 31001580 DOI: 10.1126/Sciadv.Aav1388 |
0.555 |
|
Show low-probability matches. |